Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ADH1C | P00326 | 3/20 | 0.39 |
| ▸ | ADH1A | P07327 | 3/20 | 0.39 |
| ▸ | ADH4 | P08319 | 3/20 | 0.39 |
| ▸ | ADH1B | P00325 | 2/20 | 0.39 |
| ▸ | ADH7 | P40394 | 2/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 2/20 | 0.32 |
| ▸ | CES1 | P23141 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3188358 | 1.00 | TSHR (0.42) | TSHRADH1CADH1AADH4ADH1B | |
| SCHEMBL3181124 | 1.00 | TSHR (0.42) | TSHRADH1CADH1AADH4ADH1B | |
| SCHEMBL3192661 | 1.00 | TSHR (0.42) | TSHRADH1CADH1AADH4ADH1B | |
| SCHEMBL3193317 | 0.98 | TSHR (0.39) | TSHRADH1CADH1AADH4ADH1B | |
| SCHEMBL6898635 | 0.90 | — | — | |
| SCHEMBL9646862 | 0.89 | TSHR (0.38) | TSHRADH1CADH1AADH4ADH1B | |
| SCHEMBL11503129 | 0.89 | TSHR (0.38) | TSHRADH1CADH1AADH4ADH1B | |
| SCHEMBL22098328 | 0.88 | TSHR (0.36) | TSHRADH1CADH1AADH4ADH1B | |
| SCHEMBL2236262 | 0.86 | TSHR (0.34) | TSHRADH1CADH1AADH4ADH1B | |
| SCHEMBL3963248 | 0.85 | SIRT2 (0.41) | TSHRSIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2670736-B1 | 9-[4-(3-CHLOR-2-FLUOR-PHENYLAMINO)-7-METHOXY-QUINAZOLIN-6-YLOXY]-1,4-DIAZA-SPIRO[5.5]UNDECAN-5-ONE DIMALEATE, USE THEREOF AS A DRUG, AND PRODUCTION THEREOF | BOEHRINGER INGELHEIM INT (DE) | 2017-03-15 | — | — | EP | claimed |
| EP-1542981-B1 | PROCESS FOR THE PREPARATION OF 2-AMINO-4,5,6,7-TETRAHYDRO-6-AMINOBENZOTHIAZOLES FROM CYCLOHEXANES AND CYCLOHEXANONES AS INTERMEDIATES | GENERICS UK LTD (GB) | 2009-07-22 | — | — | EP | claimed |
| EP-0750618-B1 | OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | UPJOHN CO (US) | 2003-02-19 | — | — | EP | claimed |
| EP-1087973-B1 | IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-01-08 | — | — | EP | claimed |
| EP-1054874-B1 | SUBSTITUTED AMINOPHENYL ISOXAZOLINE DERIVATIVES USEFUL AS ANTIMICROBIALS | UPJOHN CO (US) | 2002-08-28 | — | — | EP | claimed |
| EP-0828741-B1 | SPIROCYCLIC AND BICYCLIC DIAZINYL AND CARBAZINYL OXAZOLIDINONES | UPJOHN CO (US) | 2001-08-29 | — | — | EP | claimed |
| EP-0759929-B1 | OXIDATION OF STEROIDS HAVING ALLYLIC GROUPS | MERCK & CO INC (US) | 2000-08-23 | — | — | EP | claimed |
| EP-0574317-B1 | A new process for the preparation of 20-keto, 21-alpha-hydroxy steroids and intermediates therefor | ROUSSEL UCLAF (FR) | 1996-10-09 | — | — | EP | claimed |
| EP-0488383-B1 | 2-beta,19-ethylene bridged steroids as aromatase inhibitors | MERRELL PHARMA INC (US) | 1996-09-11 | — | — | EP | claimed |
| EP-0574317-A1 | A new process for the preparation of 20-keto, 21-alpha-hydroxy steroids and intermediates therefor | ROUSSEL UCLAF (FR) | 1993-12-15 | — | — | EP | claimed |
| EP-0100046-B1 | CIS-4A-ARYL-1,2,3,4,4A,9B-HEXAHYDRO-BENZOFURO(3,2-C)PYRIDINES, A PROCESS FOR PREPARING THE SAME, AND THEIR USE AS MEDICAMENTS | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1988-02-03 | — | — | EP | claimed |
| EP-1309594-B1 | BENZIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI AVENTIS (FR) | 2004-12-15 | — | — | EP | disclosed |
| EP-1309594-A1 | BENZIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | Sanofi-Aventis (FR) | 2003-05-14 | — | — | EP | disclosed |
| WO-2002012239-A1 | BENZIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI-SYNTHELABO (FR) | 2002-02-14 | — | — | WO | disclosed |
| EP-0574317-B1 | A new process for the preparation of 20-keto, 21-alpha-hydroxy steroids and intermediates therefor | ROUSSEL UCLAF (FR) | 1996-10-09 | — | — | EP | disclosed |
| EP-0574317-A1 | A new process for the preparation of 20-keto, 21-alpha-hydroxy steroids and intermediates therefor | ROUSSEL UCLAF (FR) | 1993-12-15 | — | — | EP | disclosed |
| EP-0059146-B1 | MEDICAMENTS DERIVED FROM 3-HYDROXY DODECAHYDRO BENZ(E) INDEN-7-ON, PRODUCTS DERIVED FROM 3-HYDROXY DODECAHYDRO BENZ(E) INDEN-7-ON AND PROCESS FOR THEIR PREPARATION | ROUSSEL-UCLAF (FR) | 1985-09-25 | — | — | EP | disclosed |
| EP-0059146-A1 | Medicaments derived from 3-hydroxy dodecahydro benz(e) inden-7-on, products derived from 3-hydroxy dodecahydro benz(e) inden-7-on and process for their preparation | ROUSSEL-UCLAF (FR) | 1982-09-01 | — | — | EP | disclosed |